From Baby Grows to Growing Babies

Non-Medical Prescribing Update Training in Paediatrics

I day
Up to 40 delegates

The Course Aim

To update prescribers on the safety and efficacy issues facing the Non-Medical Prescriber caring for neonates, babies and children and how to ensure appropriate prescribing.


Learning outcomes 

By the end of the session participants will have an increased understanding of:
• Legal and professional responsibilities when prescribing for neonates, babies and young people
• Pharmacokinetic and dynamic considerations • Licensed and un-licensed medicines
• Choosing the right formulation
• Factors affecting concordance (or is it compliance!)
• Treatment and consideration of common childhood ailments

Course content

• Discussing the issue of children being “Therapeutic Orphans”
• Exploring whether children’s medicine practice is really different from that of adults
• Understanding why efficacy and toxicity of medicines may be understood by their kinetic make up.
• What influences compliance with medicines throughout childhood?
• The ethics of creating licensed medicines for children; do we need them and where does it leave the prescriber?
• Current topical treatment issues, including pain fever, GORD, bronchiolitis, asthma (and other issues you may have)



Steve Tomlin is the Chief Pharmacist of Great Ormond Street Hospital and has worked in the field of children’s medicines for over 25 years across several London teaching hospitals.

He has large educational and research commitments, both within and external to the hospital. His main fields of expertise are paediatric medicines safety, medicines compliance, neonatal pharmacology and parenteral nutrition.

For many years he has been the professional secretary of the Neonatal and Paediatric Pharmacists Group (NPPG), allowing him to represent paediatric pharmacy on many national forums and the media.

He works closely with the Royal College of Paediatrics and Child Health (RCPCH), Royal Pharmaceutical Society (RPS), BNF-C and Department of Health (DH).